New Zealand markets closed

Tiziana Life Sciences Ltd (TLSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4540+0.0219 (+5.07%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Cost of revenue
0
-
0
0
Gross profit
0
-
0
0
Operating expenses
Research development
8,779
12,955
13,208
5,993
Selling general and administrative
-
0
855
13,214
Total operating expenses
18,765
14,586
27,374
30,410
Operating income or loss
-18,765
-14,586
-27,374
-30,410
Interest expense
12
7
176
320
Total other income/expenses net
-
-804
893
2,384
Income before tax
-19,501
-15,397
-26,657
-28,338
Income tax expense
0
0
-3,240
-2,207
Income from continuing operations
-19,501
-15,397
-23,417
-26,131
Net income
-19,501
-15,397
-23,417
-26,131
Net income available to common shareholders
-19,501
-15,397
-23,417
-26,131
Basic EPS
-0.18
-0.15
-0.24
-0.27
Diluted EPS
-0.18
-0.15
-0.24
-0.27
Basic average shares
103,697
101,526
97,932
97,306
Diluted average shares
103,697
101,526
97,932
97,306